Extensively drug-resistant tuberculosis

Results 161 to 170 of about 58,659 (191)

Some of the next articles are maybe not open access.

Predictors of Extensively Drug-Resistant Pulmonary Tuberculosis

Annals of Internal Medicine, 2009
About 40 000 cases of extensively drug-resistant tuberculosis emerge worldwide annually, but the predictors of extensive drug resistance are unclear.To identify risk factors for extensively drug-resistant tuberculosis and multidrug-resistant but non-extensively drug-resistant tuberculosis in patients with culture-confirmed pulmonary tuberculosis.Cross ...
Kai, Kliiman, Alan, Altraja
openaire +2 more sources

Extensively Drug-resistant Tuberculosis: Epidemiology and Management Challenges

Infectious Disease Clinics of North America, 2010
Widespread global use of rifampin for 2 decades preceded the emergence of clinically significant multidrug-resistant tuberculosis (MDR-TB) in the early 1990s. The prevalence of MDR-TB has gradually increased such that it accounts for approximately 5% of the global case burden of disease (approximately half a million cases in 2007).
Dheda, Keertan +3 more
openaire +2 more sources

Drug-resistant and extensively drug-resistant tuberculosis in southern Africa

Current Opinion in Pulmonary Medicine, 2010
Drug-resistant tuberculosis (TB) is of increasing global concern. One of the hardest hit regions is southern Africa. This study focuses on a concise update on recently published developments in the field.There is mounting evidence from high-coprevalence areas that the TB and HIV pandemics must be viewed as an entity and tackled together.
openaire +3 more sources

Extensively Drug-Resistant Tuberculosis

2023
Sheng-xiu Lv +5 more
openaire +1 more source

Anti-tuberculosis treatment strategies and drug development: challenges and priorities

Nature Reviews Microbiology, 2022
Véronique A Dartois, Eric J Rubin
exaly

Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies

Ca-A Cancer Journal for Clinicians, 2022
Paolo Tarantino +2 more
exaly

Linezolid for Extensively Drug-Resistant Tuberculosis